Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome

[1]  S. Richards,et al.  Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia. , 2003, Blood.

[2]  A. Green,et al.  Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia. , 2003, Blood.

[3]  C. Sebban,et al.  Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period , 2001, Leukemia.

[4]  W. Bleyer,et al.  Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995 , 2000, Leukemia.

[5]  J. Harbott,et al.  Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995 , 2000, Leukemia.

[6]  G. Gustafsson,et al.  Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation , 2000, Leukemia.

[7]  H. Cavé,et al.  Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report , 2000, Leukemia.

[8]  J. Shuster,et al.  Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986–1994 , 2000, Leukemia.

[9]  F. Mandelli,et al.  Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Acute Lymphoblastic Leukemia Studies, 1982–1995 , 2000, Leukemia.

[10]  F. Behm,et al.  Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital , 2000, Leukemia.

[11]  Y. Hayashi,et al.  Long-term follow-up of childhood acute lymphoblastic leukemia in Tokyo Children's Cancer Study Group 1981–1995 , 2000, Leukemia.

[12]  A. Berg,et al.  Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984–1991 , 2000, Leukemia.

[13]  S. Richards,et al.  Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980–1997 , 2000, Leukemia.

[14]  G. Janka‐Schaub,et al.  Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92 , 2000, Leukemia.

[15]  P S Gaynon,et al.  Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes). , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  C. Pui,et al.  Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. , 2000, The New England journal of medicine.

[17]  N. Heerema,et al.  Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group. , 1999, Blood.

[18]  D. Arthur,et al.  Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) – a report of the Children’s Cancer Group , 1999, Leukemia.

[19]  N. Heerema,et al.  Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  A. Borkhardt,et al.  Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. , 1997, Blood.

[21]  P. Burton,et al.  Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome. , 1997, Blood.

[22]  M. Amylon,et al.  Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with p16/p15 deletions. , 1997, Leukemia research.

[23]  E. Thiel,et al.  Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia , 1996, British journal of haematology.

[24]  G. Meloni,et al.  Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction) , 1996, Blood.

[25]  B. Johansson,et al.  Primary vs. secondary neoplasia‐associated chromosomal abnormalities—balanced rearrangements vs. genomic imbalances? , 1996, Genes, chromosomes & cancer.

[26]  A. Borkhardt,et al.  Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92. , 1996, Leukemia.

[27]  S. Hunger,et al.  Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. , 1996, Blood.

[28]  S. Shurtleff,et al.  TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. , 1995, Leukemia.

[29]  S. Clifton,et al.  Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation. , 1995, Genomics.

[30]  G. Nanjangud,et al.  Karyotypic findings as an independent prognostic marker in chronic myeloid leukaemia blast crisis. , 1994, Leukemia research.

[31]  C. Bloomfield,et al.  Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762). , 1992, Blood.

[32]  A. Look,et al.  Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. , 1992, Blood.

[33]  L. Frankel,et al.  Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  E. Thiel,et al.  Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction , 1991, The Lancet.

[35]  J. Craig,et al.  Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance. , 1991, Leukemia.

[36]  J. Shuster,et al.  Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1991, Blood.

[37]  J J Shuster,et al.  Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases. , 1991, Blood.

[38]  F. Behm,et al.  Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study , 1990 .

[39]  C. Bloomfield,et al.  Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. , 1989, Cancer genetics and cytogenetics.

[40]  F. Behm,et al.  Nonrandom abnormalities of chromosome 9p in childhood acute lymphoblastic leukemia: association with high-risk clinical features. , 1989, Blood.

[41]  C. Bloomfield,et al.  Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia. , 1984, Cancer genetics and cytogenetics.

[42]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[43]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[44]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[45]  John M. Walker,et al.  Myeloid Leukemia , 2020, Methods In Molecular Medicine™.

[46]  A. Green,et al.  chromosome 9 in chronic myeloid leukemia Double jeopardy from a single translocation : deletions of the derivative , 2003 .

[47]  J. Harbott,et al.  Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster. , 2000, Leukemia.

[48]  A. Moghrabi,et al.  Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981–1995) , 2000, Leukemia.

[49]  N. Heerema,et al.  Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy. , 1999, Leukemia & lymphoma.

[50]  M. Zhou,et al.  Incidence and clinical significance of CDKN2/MTS1/P16ink4A and MTS2/P15ink4B gene deletions in childhood acute lymphoblastic leukemia. , 1997, Pediatric hematology and oncology.

[51]  C. Pui,et al.  Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  M. Boermeester,et al.  Clinical significance of translocation. , 1994, Gut.

[53]  R Mastrangelo,et al.  Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment. , 1986, Medical and pediatric oncology.

[54]  J. Whang‐Peng.  Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia , 1981 .

[55]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .